Abstract

Objective To compare the effects of body mass index and waist circumference on the risk of metabolic syndrome(MS) in obese subjects. Methods Since 2000 a seven-year follow-up study was conducted in 554 subjects(316 men and 238 women), including 192 subjects with peripheral obesity, 135 with central obesity and 237 with mixed obesity. Before and after the follow-up, adiposity, blood pressure, lipid profile, fasting blood glucose and 2 h blood glucose after glucose loading were measured. Results 520 of 554 subjects were followed up in 2007. Seven-year cumulative incidence of MS was 26.3% (49/186) in subjects with peripheral obesity, 41.7 % (50/120)in those with central obesity and 43.0% (92/214 )with mixed obesity. The eumulative incidence of MS in subjects with central obesity and mixed obesity were higher than that in subjects with peripheral obesity(X^2 = 7. 825 and X^2 = 12. 082, respectively, both P〈0.01 ) , and the basal levels of diastolic blood pressure,triglyeeride, fasting blood glucose, fasting insulin and insulin resistance index (HOMA-IR) were significantly increased in the former group than the latter( all P〈0.05 ). Compared with obese subjects without MS, waist eircumference, waist-hip ratio, fasting blood glueose, fasting insulin and insulin HOMA-IR were significantly increased in subjects with MS ( P〈0.01 or P〈0.05 ) and there was no difference in body mass index between two groups. Logistic analysis showed that waist circumference (P = 0.021 ) , waist-to-hip ratio (P = 0. 009 ) and HOMA-IR(P=0. 004)were major risk faetors of developing MS. Conclusion Central obesity and insulin resistance play a very important role in developing MS, and the effect of waist circumference is a more important risk of MS than body mass index. Key words: Body mass index; Waist eireumferenee; Metabolic syndrome; Follow-up study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call